Standards of PracticePosition Statement on Percutaneous Vertebral Augmentation: A Consensus Statement Developed by the Society of Interventional Radiology (SIR), American Association of Neurological Surgeons (AANS) and the Congress of Neurological Surgeons (CNS), American College of Radiology (ACR), American Society of Neuroradiology (ASNR), American Society of Spine Radiology (ASSR), Canadian Interventional Radiology Association (CIRA), and the Society of NeuroInterventional Surgery (SNIS)
Section snippets
Vertebral Augmentation versus Nonoperative Medical Treatment
Nonoperative medical treatment of VCFs has often been described as “conservative” or “traditional” management. As we have stated previously, although “conservative” implies “safe,” such therapy is neither benign nor risk-free, and its complications are well documented (98, 99, 100). Nonoperative medical treatment of painful VCFs usually consists of bedrest, bracing, and narcotic analgesia. In a prospective study of 498 hospitalized patients age 70 years or older (97), low mobility (defined as
Conclusions
It is the position of the Societies that PVA remains a proven medically appropriate therapy for treatment of painful VCFs refractory to nonoperative medical therapy and for vertebrae weakened by neoplasia when performed for the medical indications outlined in the published standards (1, 2, 3, 4).
References (161)
- et al.
Quality improvement guidelines for percutaneous vertebroplasty
J Vasc Interv Radiol
(2003) - et al.
Percutaneous vertebroplasty with polymethylmethacrylate. Technique, indications and results
Radiol Clin N Am
(1998) - et al.
Vertebroplasty: clinical experience and follow-up results
Bone
(1999) - et al.
Predictors of successful palliation of compression fractures with vertebral augmentation: single-center experience of 525 cases
J Vasc Interv Radiol
(2009) - et al.
Prospective evaluation of pain relief in 100 patients undergoing percutaneous vertebroplasty: results and follow-up
J Vasc Interv Radiol
(2002) - et al.
Percutaneous vertebroplasty for osteoporotic compression fractures: quantitative prospective evaluation of long-term outcomes
J Vasc Interv Radiol
(2002) - et al.
Management of acute osteoporotic vertebral fractures: a non-randomized trial comparing percutaneous vertebroplasty with conservative therapy
Am J Med
(2003) - et al.
Prospective clinical follow-up after percutaneous vertebroplasty in patients with painful osteoporotic vertebral compression fractures
J Vasc Interv Radiol
(2006) - et al.
Vertebroplasty versus conservative treatment in acute osteoporotic vertebral compression fractures (VERTOS II): an open-label randomised trial
Lancet
(2010) - et al.
Percutaneous balloon kyphoplasty for the correction of spinal deformity in painful vertebral body compression fractures
Clin Imaging
(2002)
Acute versus chronic vertebral compression fractures treated with kyphoplasty: early results
Spine J
Minimally invasive treatment of osteoporotic vertebral body compression fractures
Spine J
A review of complications associated with vertebroplasty and kyphoplasty as reported to the food and drug administration medical device related web site
J Vasc Interv Radiol
Preliminary outcomes and efficacy of the first 360 consecutive kyphoplasties for the treatment of painful osteoporotic vertebral compression fractures
Spine J
Efficacy and safety of balloon kyphoplasty compared with non-surgical care for vertebral compression fracture (FREE): a randomised controlled trial
Lancet
Pain and functional outcome after vertebroplasty and kyphoplasty. A comparative study
Eur J Radiol
Vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: an evidenced-based review of the literature
Spine J
Vertebroplasty and kyphoplasty
Anesthesiol Clin
Comparison of vertebroplasty and balloon kyphoplasty for treatment of vertebral compression fractures: a meta-analysis of the literature
Spine J
Respective contributions of vertebroplasty and kyphoplasty to the management of osteoporotic vertebral fractures
Joint Bone Spine
Is kyphoplasty better than vertebroplasty in restoring normal mechanical function to an injured spine?
Bone
Percutaneous vertebral augmentation: vertebroplasty, kyphoplasty and skyphoplasty
Radiol Clin North Am
“SKyphoplasty”: a single institution’s initial experience
J Vasc Interv Radiol
Evidence on the effectiveness and cost-effectiveness of vertebroplasty: A review of policy makers’ responses
Acad Radiol
Tolerability of opioids in patients with acute pain due to nonmalignant musculoskeletal disease. A hospital-based observational study
Joint Bone Spine
Note préliminaire sur le traitement des angiomes vertébraux par vertebroplastie percutanée
Neurochirurgie
Vertébroplastie percutanée dans le traitement des métastases. Technique et résultats
J Radiol
Percutaneous vertebroplasty with acrylic cement in the treatment of aggressive spinal angiomas
Rachis
Percutaneous vertebroplasty with acrylic cement in the treatment of osteoporotic vertebral crush fracture syndrome
Neuroradiology
Percutaneous vertebroplasty guided by a combination of CT and fluoroscopy
AJNR Am J Neuroradiol
Percutaneous vertebroplasty for osteolytic metastases and myeloma: effects of the percentage of lesion filling and the leakage of methyl methacrylate at clinical follow-up
Radiology
Spinal metastases: indications for and results of percutaneous injection of acrylic cement
Radiology
Percutaneous polymethylmethacrylate vertebroplasty in the treatment of osteoporotic vertebral body compression fractures: technical aspects
AJNR Am J Neuroradiol
Percutaneous vertebroplasty: state of the art
Radiographics
Percutaneous vertebroplasty: indications, technique, and results
Radiographics
Percutaneous vertebroplasty for pain relief and spinal stabilization
Spine
Age of fracture and clinical outcomes of percutaneous vertebroplasty
AJNR Am J Neuroradiol
Percutaneous vertebroplasty in osteoporotic vertebral compression fractures: our initial experience
J Pak Med Assoc
Percutaneous vertebroplasty: the follow-up
Radiol Med
Percutaneous vertebroplasty for osteoporotic fractures
Pain Physician
Vertebroplasty in the treatment of osteoporotic vertebral fractures: results and functional outcome in a series of 175 consecutive patients
Minim Invasive Neurosurg
Vertebroplasty, first 1000 levels of a single center: evaluation of the outcomes and complications
AJNR Am J Neuroradiol
Vertebral compression fractures: pain reduction and improvement in functional mobility after percutaneous polymethylmethacrylate vertebroplasty retrospective report of 245 cases
Radiology
Long-term observations of vertebral osteoporotic fractures treated by percutaneous vertebroplasty
Rheumatology
Percutaneous vertebroplasty in the treatment of osteoporotic vertebral compression fractures: an open prospective study
J Rheumatol
Percutaneous transpedicular vertebroplasty with PMMA: operative technique and early results. A prospective study for the treatment of osteoporotic compression fractures
Eur Spine J
Cited by (94)
Treatment Strategies in the Osteoporotic Spine
2024, Orthopedic Clinics of North AmericaACR Appropriateness Criteria® Management of Vertebral Compression Fractures: 2022 Update
2023, Journal of the American College of RadiologyPercutaneous vertebral augmentation for acute traumatic vertebral Fractures: A TQIP database study
2023, Journal of Clinical NeuroscienceRole of biophysical stimulation in multimodal management of vertebral compression fractures
2023, Computational and Structural Biotechnology Journal
The initial version of this document first appeared in J Vasc Interv Radiol 2007; 18:325–330 and 2009; 20(suppl):S326–S331.
J.D.B. owns shares in Spine Wave (Shelton, Connecticut). J.K.M. receives royalties from Cook (Bloomington, Indiana) and owns stock in Dfine (San Jose, California). A.L.B. is a paid consultant for DePuy (Raynam, Massachusetts). J.E.O. is a paid consultant for and receives royalties from Globus Medical (Audubon, Pennsylvania) and Pioneer Surgical (Marquette, Michigan). T.C.R. is a paid consultant for Medtronic (Minneapolis, Minnesota) and Arbor Pharmaceuticals (Atlanta, Georgia). S.M.T. is a paid consultant for Benvenue Medical (Santa Clara, California). None of the other authors have identified a conflict of interest.